Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Depreciation and Depletion (2020 - 2025)

Mesa Laboratories' Depreciation and Depletion history spans 6 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion rose 14.83% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $5.3 million, up 28.44%, while the annual FY2025 figure was $5.4 million, 77.57% up from the prior year.
  • Depreciation and Depletion for Q4 2025 was $1.3 million at Mesa Laboratories, down from $1.3 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $1.5 million in Q3 2024 and bottomed at $132000.0 in Q1 2024.
  • The 3-year median for Depreciation and Depletion is $1.2 million (2023), against an average of $1.1 million.
  • The largest annual shift saw Depreciation and Depletion tumbled 88.18% in 2024 before it soared 925.76% in 2025.
  • A 3-year view of Depreciation and Depletion shows it stood at $1.1 million in 2023, then grew by 2.98% to $1.1 million in 2024, then grew by 14.83% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Depreciation and Depletion are $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $1.4 million (Q2 2025).